Radius Recycling - RDUS Net Assets per Single Share

Graphic logo of Radius Recycling, Inc. (RDUS)

Biopharmaceutical risks stemming from sanctions and patent disputes are weighing on quotes; therefore, the fair book value of the Radius Recycling, Inc. (RDUS) share on GURU.Markets incorporates data on real assets, where 18.66 forms the current metric indicator. Business stability relies on global metal prices, while the survival strategy is based on rigorous internal optimization and the avoidance of mergers to preserve liquidity.

Radius Recycling Inc. (RDUS): Share Book Value from 07/04/2022 to 07/26/2025

radiuspharm.com - analytical breakdowns and key metrics (RDUS)

- price and consensus price forecast:
Stock Quotes Radius Health|RDUS - Analyst Consensus Forecast
- market capitalization data:
Market Value Radius Recycling, Inc.|RDUS - Company Buyout Price
- book capitalization data:
Net Assets per Single Share Radius Recycling|RDUS - Net Asset Value|Market Capitalization to Book Value Ratio radiuspharm.com|RDUS - Aggregate Asset Value
- debt and liquidity data:
Total Debt to Capital Radius Recycling, Inc.|RDUS - Long-Term Debt to Capital|Short-Term Debt to Equity Radius Recycling|RDUS - Aggregate Debt Obligations|Debt to Book Capitalization Ratio Radius Recycling, Inc.
Fundamental company valuation:Radius Health - RDUS
Manufactured products of Radius Recycling

Radius Recycling, Inc. (RDUS) extensive R&D investments in molecular biology define its capital structure, where the BVPS chart reflects the dynamics of net equity per share. This metric allows for an assessment of the real value of assets net of liabilities, demonstrating the company's ability to accumulate internal resources for the development of orphan disease therapies and confirming the fundamental resilience of the business.

Competitors of Radius Recycling, Inc. (RDUS)

Ascendis Pharma Inc. - Accounting Value per Share|MDGL: Book Value per Share|Corcept Therapeutics - Net Assets per Single Share|RYTM (rhythmtx.com) - Net Assets per Share|Net Assets per Single Share Akero AKRO|Share Book Value Metsera, Inc.|MoonLake Pharma (MLTX) - Book Value per Share|Accounting Value of a Share Crinetics Corp (CRNX)|Book Value per Share NAMS (NewAmsterdam Pharma)|soleno.life - Book Value per Share|Net Assets per Single Share Amicus Therapeutics, Inc. (FOLD)|ETNB: Accounting Value of a Share|AGIO (Agios Pharmaceuticals Inc) - Net Assets per Single Share|Structure Corp (GPCR) - Accounting Value per Share|MDXG (MiMedx Group, Inc.) - Book Value per Share|Book Value per Share rezolutebio.com (RZLT)|Lexicon Pharmaceuticals, Inc. (LXRX) - Accounting Value per Share|Accounting Value of a Share MBX (MBX Biosciences, Inc.)|Altimmune Corp - Net Assets per Single Share|Accounting Value per Share Aardvark Pharma AARD|SGMT (Sagimet Biosciences) - Book Value per Share|bioagelabs.com (BIOA) - Net Asset Value per Share|BMEA - Accounting Value per Share|Quince Therapeutics, Inc. (QNCX) - Book Price of a Share|GUTS (Fractyl) - Book Value per Share|Book Value per Share vTv Therapeutics Inc|Book Value per Share Agape ATP Corporation (ATPC)|Net Assets per Single Share PLUR (pluri-biotech.com)|SYBX: Net Assets per Single Share|Lipocine Inc - Net Asset Value per Share|MTNB - Net Assets per Single Share|SPRB - Net Assets per Single Share|Galecto, Inc. - Book Value per Share|CTCX (carmellrx.com) - Net Assets per Share|LUMO: Net Assets per Single Share|Net Assets per Share ONVO